Another suggested biomarker, the ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF), has been reported as elevated in pregnant women before clinical onset of preeclampsia and eclampsia [31, 32]. This evidence concerns the gene PGF and preeclampsia.